Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.

European journal of gastroenterology & hepatology - 1 Feb 1998

Mazzoran L, Tamaro G, Mangiarotti M A, Marchi P, Baracetti S, Gerini U, Fanni-Cannelles M, Zorat F, Pozzato G

Abstract excerpt

OBJECTIVE: To evaluate serum levels of prolyl-hydroxylase and helical domain of Type IV collagen, markers of hepatic fibrogenesis, in patients with HCV-positive chronic liver disease and the effects of interferon therapy on these markers. DESIGN: Prolyl-hydroxylase and Type IV collagen were determined before therapy and each month during the treatment and follow-up. METHODS: Fifty-seven HCV-positive patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Collagen

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C

Share to RNA, Viral

Source

Identifiers

PMID: 9581987
DOI: 10.1097/00042737-199802000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.PMID 9581987Read ↗

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.Semantic proximity Read ↗

Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study.Semantic proximity Read ↗

Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.Semantic proximity Read ↗

Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection.Semantic proximity Read ↗

[Interferon treatment of chronic hepatitis C: basic immunobiology and immunopathology of the liver].Semantic proximity Read ↗

Association between risk factors, basal viral load, virus genotype and the degree of liver fibrosis with the response to the therapy in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Inflammation and repair in viral hepatitis C.Semantic proximity Read ↗

Plasma TIMP-1 is a Useful Tool for Monitoring 24 Months Liver Fibrosis Improvement After Anti-HCV /DAA Therapy in HCV/HIV Mono/CoinfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.